Navigation Links
Choose your love
Date:1/23/2014

To test whether female mate choice enhances the health and disease-resistance of offspring, either through immune resistance, tolerance to infection, or both, researchers led by Dustin Penn tested female house mice's preferences (Mus musculus) for particular males and then experimentally assigned each female to mate with either their preferred or their non-preferred male. They found that females that mated with their preferred male produced more offspring and were better able to cope with infection (from Salmonella, a common mouse pathogen) compared to offspring sired by non-preferred males. They were no better at controlling pathogen loads than offspring from non-preferred males, which suggests that the fitness benefits were due to tolerance to infection rather than immune resistance (the ability to control or eliminate pathogens) per se.

In 1982, Hamilton and Zuk suggested that mate choice enables females to select healthy, disease-resistant males, and produce disease-resistant offspring. Since then many studies have confirmed that showy secondary sexual traits provide information about males' immune resistance and parasite loads, and females are more attracted to healthy males. Doubts have remained about the hypothesis, however, partly because studies so far have mainly measured disease-resistance indirectly, assessing parasite loads or immune responses to antigens, which do not necessarily reflect health and disease-resistance.

This study provides direct experimental evidence that females' partner preferences enhance the ability of offspring to cope with infection in house mice. The authors suggest that females assess males' overall condition and health rather than immune resistance per se, and for this reason, sexual selection should enhance offspring tolerance, as well as immune resistance to infection. Penn and others have shown that ability to resist and survive Salmonella infection is influenced by MHC genes a
'/>"/>

Contact: Dustin Penn
dustin.penn@vetmeduni.ac.at
43-148-909-15823
University of Veterinary Medicine -- Vienna
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Dominant deer hinds choose the best food
2. Stryker Chooses Wineman Technology for Medical Device Test Equipment and Software
3. South Africas Capitec Bank Chooses Diebold Cash Recycling ATMs
4. Friend or foe: Babies choose sides early
5. High-testosterone competitors more likely to choose red
6. Schools help kids choose carrots over candy bars
7. Boost careers of female scientists: Make sure women help choose meeting speakers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Choose your love
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/30/2015)... 2015 Cellecta, Inc., a U.S.-based provider ... and biomarker discovery, announced the release of its ... all human protein coding genes. CRISPR technology enables ... gene,s function. Cellecta,s new Human Whole Genome CRISPR ... so that researchers can investigate in a single ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... heart becomes diseased during its embryonic/fetal development, it can ... fully functional by birth, provided some of the heart ... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch made this ... to demonstrate in female mice that the healthy cells ...
... in Cancer Research , a journal of the American ... in breast tumor development and metastases. The study, ... is among the first to explore the effects of nicotine ... role of nicotine exposure in tumor promotion, little is known ...
... broadleaf weeds in corn, but also annihilated most of ... finally have a worthy contender. Researchers at the University ... Chancellor which is resistant to the popular herbicide 2, ... introduced. It was a wonder herbicide," said Robert Skirvin, ...
Cached Biology News:Repair in the developing heart 2Study links nicotine with breast cancer growth and spread 2Herbicide-resistant grape could revitalize Midwest wine industry 2Herbicide-resistant grape could revitalize Midwest wine industry 3
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
(Date:7/29/2015)... July 30, 2015 Sanofi, ... for the second quarter of 2015. CEO ... and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in ... - Performance drivers - ...
(Date:7/29/2015)... July 30, 2015 According to a ... Growth, Trends & Forecasts (2015-2020), , published by Mordor Intelligence, ... billion by the end of 2020, with North ... more than 40% of the global market size. The Global ... CAGR of 13.7% during the period of (2015-2020). ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... , PALO ALTO, Calif., Sept. 21 Varian, ... to enhance the flexibility and automated use of its 400-MR ... comprises the OneNMR(TM) probe, a choice of two autosamplers, and ... sample throughput and streamlined data management in mind, each piece ...
... LONDON and SAN CARLOS, Calif., Sept. 21 ... into an exclusive worldwide license agreement for two drug development ... the treatment of opioid-induced constipation, and the NKTR-119 programme, an ... the treatment of pain without constipation side effects. Both ...
... a lattice of carbon just a single atom deep ... sensors so keen they detect the arrival or departure ... in fuel cells or as energy‐saving transistors and wires. ... abundant material, have so much potential because their function ...
Cached Biology Technology:New Productivity Suite From Varian, Inc. Increases Throughput for NMR Laboratories 2New Productivity Suite From Varian, Inc. Increases Throughput for NMR Laboratories 3AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 2AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 3AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 4AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 5A recipe for controlling carbon nanotubes 2